6XS Stock Overview
Cel AI PLC, together with its subsidiaries, engages in the manufacture and sale of biosynthetic cannabinoids-based consumer products in the United Kingdom.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Cel AI PLC Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.0045 |
| 52 Week High | UK£0.015 |
| 52 Week Low | UK£0.001 |
| Beta | -1.5 |
| 1 Month Change | 0% |
| 3 Month Change | -55.00% |
| 1 Year Change | -65.38% |
| 3 Year Change | -95.88% |
| 5 Year Change | n/a |
| Change since IPO | -97.17% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6XS | DE Personal Products | DE Market | |
|---|---|---|---|
| 7D | 0% | -0.2% | -0.8% |
| 1Y | -65.4% | -5.2% | 1.0% |
Return vs Industry: 6XS underperformed the German Personal Products industry which returned -5.2% over the past year.
Return vs Market: 6XS underperformed the German Market which returned 1% over the past year.
Price Volatility
| 6XS volatility | |
|---|---|
| 6XS Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 4.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 9.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 6XS's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 6XS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | 5 | n/a | www.getcel.ai |
Cel AI PLC, together with its subsidiaries, engages in the manufacture and sale of biosynthetic cannabinoids-based consumer products in the United Kingdom. The company provides cannabinoid solutions for skincare and ingestible products. It offers its products through retailers; direct to consumers through its website; and online.
Cel AI PLC Fundamentals Summary
| 6XS fundamental statistics | |
|---|---|
| Market cap | €1.59m |
| Earnings (TTM) | -€3.87m |
| Revenue (TTM) | €78.66k |
20.2x
P/S Ratio-0.4x
P/E RatioIs 6XS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6XS income statement (TTM) | |
|---|---|
| Revenue | UK£67.24k |
| Cost of Revenue | UK£25.80k |
| Gross Profit | UK£41.44k |
| Other Expenses | UK£3.35m |
| Earnings | -UK£3.31m |
Last Reported Earnings
Aug 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0055 |
| Gross Margin | 61.63% |
| Net Profit Margin | -4,922.54% |
| Debt/Equity Ratio | 0% |
How did 6XS perform over the long term?
See historical performance and comparison